Advertisement

Topics

REMD Biotherapeutics, Inc. Company Profile

05:57 EDT 26th June 2019 | BioPortfolio

REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic diseases and other serious illnesses. The Company was founded by two former Amgen research scientists and has facilities in Camarillo, California and Beijing China (Cosci-REMD Biotherapeutics). Our lead product candidate, REMD-477—a fully human antibody to the glucagon receptor—is presently in clinical studies for treatment of diabetes as well as in preclinical studies for treatment of other metabolic disorders. Our discovery research leverages our extensive expertise in generating and developing therapeutic antibodies to G protein-coupled receptors (GPCRs) as well as to other multi-transmembrane cell surface antigens.


News Articles [234 Associated News Articles listed on BioPortfolio]

GenScript Biotech & REMD Biotherapeutics Inc. Reached a Strategic Collaboration to Develop Several Bispecific Antibodies

Apr. 26, 2019 Nanjing, China · Camarillo, California, US —— GenScript Biotech Corporation, a world leading bio-pharmaceutical CDMO company, has entered into an exclusive strategic drug developmen...

Evotec to acquire biologics company Just Biotherapeutics

Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN. Just Biotherapeutics provides machine-learning...Read More.....

Evotec Pays $90 Million for Just Biotherapeutics

German drug discovery and development company Evotec has signed an agreement to buy Just Biotherapeutics, a US biologics company. Founded in 2014, Just Biotherapeutics is backed by investors that incl...

DGAP-Adhoc: Evotec SE akquiriert Just Biotherapeutics, Inc. (deutsch)

Evotec SE akquiriert Just Biotherapeutics, Inc. DGAP-Ad-hoc: Evotec SE / Schlagwort(e): Firmenübernahme Evotec SE akquiriert Just Biotherapeutics, Inc. 20.05.2019 / 22:24 CET/CEST Veröffentlichung ....

Iovance Biotherapeutics to build cell therapies plant in US

Iovance Biotherapeutics has announced plans to construct a commercial-scale production facility in Philadelphia, US. This 136,000ft2 plant will be used...Read More... The post Iovance Biotherapeutics ...

FDA fast-tracks Iovance Biotherapeutics' cervical cancer drug

Iovance Biotherapeutics' LN-145, which is in midstage development to treat patients with recurrent or metastatic cervical can -More- 

Evotec kauft Just Biotherapeutics für bis zu 81 Mio EUR

FRANKFURT (Dow Jones)--Evotec kauft in den USA zu. Für umgerechnet bis zu 81 Millionen Euro übernimmt das Unternehmen die in Seattle ansässige Just Biotherapeutics. Der Kaufpreis schließe eine pot...

Evotec To Buy Just Biotherapeutics For Up To US$90 Mln

HAMBURG (dpa-AFX) - Evotec SE (EVTCY.PK, EVOTF.PK) said that it agreed to acquire Just Biotherapeutics Inc. based in Seattle, WA, USA for up to US$90 million or about 81 million euros including po...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Atryn [gtc biotherapeutics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Winrho [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use WinRho SDF safely and effectively. See full prescribing information for WinRho SDF. WinRho SDF [Rho(D) Immune Globulin Intravenous (Hu...

Ixinity [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use IXINITY® safely and effectively. See full prescribing information for IXINITY.. IXINITY [coagulation factor IX (recombinant)] Lyophil...

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Multidimensional Replica Exchange simulations for Efficient constant pH and Redox Potential Molecular Dynamics.

Efficient computational methods that are capable of supporting experimental measures obtained at constant values of pH and redox potential are important tools as they serve to, among other things, pro...

Sleep alterations in pediatric bipolar disorder versus attention deficit disorder.

Bipolar disorder (BD) and attention deficit/hyperactivity disorder (ADHD) share numerous clinical features, which can make the differential diagnosis challenging. Studies conducted in adults suggest t...

Probable Transmembrane Amyloid α-Helix Bundles Capable of Conducting Ca Ions.

Amyloid beta (Aβ) peptides are considered the major causative agents of Alzheimer's disease (AD). In a widely accepted mechanism for AD pathogenesis, Aβ peptides are proposed to play multiple roles ...

Reliable LC-MS Multi-Attribute Method for Biotherapeutics by Run-Time Response Calibration.

A major challenge of a mass spectrometry-based quantitative multi-attribute method (MAM) for biotherapeutics is its high variability between instruments. For reproducible attribute measurements, not o...

Computational Methods for Studying Conformational Behaviors of Cyclic Peptides.

Molecular dynamics (MD) simulations play more and more important roles in studying conformations of cyclic peptides in solution. Here we describe how to use replica-exchange molecular dynamics (REMD) ...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

This is a randomized, placebo-controlled, double-blind study to evaluate safety, tolerability and pharmacodynamics of REMD-477 in subjects who have Type 1 diabetes and are currently receiv...

The Effects of a GRA on Non-Glucose Metabolic Pathways in Patients With Type 1 Diabetes (Pilot Study)

A pilot study for individuals with Type 1 Diabetes who are willing to add a GRA (Glucagon Receptor Antagonist) to their current Diabetes treatment regimen. There will be 10 study visits ov...

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

The Effect of OASIS Ultra on Critical Sized Wound Healing

The aim of this study is to evaluate the speed and quality with which OASIS® Ultra (Healthpoint Biotherapeutics; Fort Worth, Texas) increases wound healing in the critical sized defect. ...

Companies [108 Associated Companies listed on BioPortfolio]

REMD Biotherapeutics, Inc.

REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic diseases an...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

EpimAb Biotherapeutics EpimAb Biotherapeutics

EpimAb Biotherapeutics is a privately-owned biopharmaceutical R&D company based in Shanghai with a proprietary and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunogl...

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

Sephos Biotherapeutics

Sephos Biotherapeutics is a privately owned company focused on designing drugs for the treatment of cancer stem cells where the structure and biological activity of the drugs have...

More Information about "REMD Biotherapeutics, Inc." on BioPortfolio

We have published hundreds of REMD Biotherapeutics, Inc. news stories on BioPortfolio along with dozens of REMD Biotherapeutics, Inc. Clinical Trials and PubMed Articles about REMD Biotherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of REMD Biotherapeutics, Inc. Companies in our database. You can also find out about relevant REMD Biotherapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record